Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
about
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and managementSelective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesVaccine protection against feline immunodeficiency virus: setting the challenge.2008 American Association of Feline Practitioners' feline retrovirus management guidelines.Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom.Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccineRapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus.A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.Feline immunodeficiency virus model for designing HIV/AIDS vaccines.Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?Feline immunodeficiency virus subtypes in domestic cats in New Zealand.Vaccine protection against feline immunodeficiency virus.Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
P2860
Q26829717-3E355300-4ABB-4726-9AE3-2AE3A23121A8Q27318192-7FAF6414-3CB2-4B32-B4E3-A6A15B188238Q34575552-2DE76BC6-FC43-4E22-93F6-17EFF7A1C26EQ34775753-7BEC94BB-67A2-4E3D-AB9B-8D5FE5DB356FQ35012759-7E0A83F3-1201-49E9-8233-31BA49B0E281Q35082956-02BB6F73-B0AD-4494-A28D-40D1ED793C4AQ35182754-1D3DAE8C-4202-45FC-A9C9-F00BA7FE1C5EQ36926701-B12E60E3-F4F6-4B02-98C3-6F587162F6EDQ37704546-0079FCD1-7866-4DFA-B94B-4E73A7B729FDQ38113162-0CACC425-36DE-4D11-B65B-5BB9FBDB1A73Q43378526-D1E782F0-8053-4E01-B898-9E58267E2EC3Q45398836-0EBB2F39-A8A6-4D34-B93B-CD472E062D46Q45401298-EA23E0B3-4B4B-4C9B-8E08-64E4538DB99CQ52375200-FAF26BDD-FCE5-4E78-BCA1-D1C3074B4AACQ52574472-E441389B-6728-4AE5-B5F4-5B371682CDDFQ53686365-DA3126C4-ACF4-4570-92D7-2916C69BA13AQ54984932-D6372F98-3760-427A-9370-1FA8418BFA83
P2860
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@ast
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@en
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@nl
type
label
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@ast
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@en
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@nl
prefLabel
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@ast
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@en
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@nl
P2093
P356
P1433
P1476
Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
@en
P2093
P304
P356
10.1136/VR.158.16.561
P407
P577
2006-04-01T00:00:00Z